Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/10/2024
NHSA and NHC Jointly Issue New Policy Document on Centralized Drug Pro...
12/10/2024
Abbisko Reports Promising Preliminary Phase 2 Data for Pimicotinib in ...
12/10/2024
Loncastuximab Tesirine Gains Approval in China for 3L r/r DLBCL Treatm...
12/10/2024
Merck's Keytruda Gains First Approval in China for Cervical Cancer Tre...
12/10/2024
Sperogenix's Vamorolone Approved in China for DMD
12/10/2024
China Biopharma CDMOs Win Reprieve as Biosecure Act Omitted from US De...
12/10/2024
Beijing Hanmi Launches $98.65M Expansion Project Near Capital Airport
12/10/2024
China Biopharma Tracker – November 2024 (PharmaDJ)
12/10/2024
How Wholly Foreign-Owned Hospitals Can Help China's Health Care Sector...
12/10/2024
The New Draft Administrative Measures For Management Of Medical Repres...
12/9/2024
Belief Biomed Unveils Promising Gene Therapy Data at ASH 2024
12/6/2024
Medical Costs in Mainland China and Hong Kong to Grow More Slowly Than...
12/6/2024
CDE Seeks Comments on Draft ICH Guidelines M15
12/6/2024
Recent Executive Moves
12/5/2024
SK Biopharm Advances Epilepsy Treatment in China with NDA Submission ...
12/5/2024
2025 Trends Buoying Boom Phase in APAC (Biospectrum)
12/5/2024
Big Pharma Doubles Down on China (The Wire China)
12/3/2024
Big Pharma's Bet on China Biotech Is a Rare Trade Bright Spot (Bloomb...
12/3/2024
CMS Gains Licenses Class 1 New Drug Targeting Gout and Hyperuricemia f...
12/3/2024
Sanofi Allocates €1 Billion for New Insulin Manufacturing Facility in...
12/3/2024
NHC Minister Meets with Sanofi and BioMérieux Bosses to Strengthen Si...
12/3/2024
PharmaMar/Luye's Lurbinectedin Gains Approval in China for Treating Me...
12/3/2024
NH DB6: Global and Chinese Consumer Healthcare Market: MAT Q2/2024 Tr...
12/3/2024
HUTCHMED and Innovent's ELUNATE and TYVYT Combo Win Chinese Condi...
12/2/2024
Everest Medicines Announces Acceptance of VELSIPITY NDA in Hong Kong
12/2/2024
Hua Medicine Announces Successful H.K. SENSITIZE Study Results at the ...
12/2/2024
Miracogen to Present Phase II Data on MRG003 at ESMO Asia 2024
12/2/2024
Zambon's Xadago (Safinamide) Gains Chinese Approval for Parkinson's Di...
12/2/2024
Minghui Pharma Reports Positive Phase III Results for MH004 in Atopic ...
12/2/2024
Merck's Recarbrio Approved in China for Severe Bacterial Pneumonia
Page:
12
/
354
Total number of articles:
10618
:
[First]
[<<]
[10]
[11]
[12]
[13]
[14]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit